Kyntra Bio, Inc.
KYNB
$7.94
-$0.10-1.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 8,966.99% | 1,735.01% | 485.57% | 277.07% | 98.77% |
| Total Depreciation and Amortization | -87.00% | -80.54% | -72.21% | -74.09% | -72.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -546.64% | -283.55% | -247.62% | -208.48% | -54.63% |
| Change in Net Operating Assets | -288.41% | -65.19% | -30.29% | -355.54% | 47.81% |
| Cash from Operations | -62.34% | 71.87% | 96.54% | 86.56% | 88.40% |
| Capital Expenditure | 96.43% | 91.30% | 85.71% | 52.39% | 74.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -75.48% | 34,666.67% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,777.99% | -178.58% | -148.84% | -101.03% | -99.12% |
| Cash from Investing | 2,192.32% | -48.52% | -71.89% | -33.94% | -98.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -366,072.73% | -244,006.06% | -201,300.00% | -89,408.89% | 77.08% |
| Issuance of Common Stock | -- | -- | -- | -85.71% | -85.71% |
| Repurchase of Common Stock | 81.61% | 83.61% | 80.51% | 77.94% | 24.02% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11,536.96% | -11,536.96% | -- | -- | -- |
| Cash from Financing | -39,143.38% | -48,184.83% | -33,636.47% | -16,897.83% | 45.39% |
| Foreign Exchange rate Adjustments | -496.45% | -117.00% | 43.41% | -46.36% | -86.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -231.51% | -14,950.43% | -371.82% | -229.13% | -75.83% |